Hip, Knee Sales Growth Slows In Second Quarter For Top Orthopedic Firms

Overall weakness in the hip-and-knee market resulted in low-single-digit reconstructive sales growth for Zimmer, Stryker and Johnson & Johnson/DePuy in the second quarter

More from Archive

More from Medtech Insight